Children with congenital heart disease (CHD) frequently require airway management during diagnostic, interventional, and surgical procedures. These children are particularly vulnerable because of altered cardiopulmonary physiology, frequent need for repeated anesthetic exposure, and prolonged postoperative ventilation. Conventional age-based formulas used to predict endotracheal tube (ETT) size in the general pediatric population are often inaccurate in children with CHD because of growth retardation, chronic hypoxemia, syndromic associations, and repeated airway instrumentation. Cole’s formula, developed in the 1950s to estimate ETT in children, remains the most popular method for determining ETT size.1 Despite advances in pediatric airway equipment, most clinicians still rely heavily on such age-based formulas developed in healthy children for ETT size selection.2 These formulas often fail to account for the unique anatomical and physiological characteristics of children with CHD. Inappropriate selection of ETT size may cause airway trauma, increased airway resistance, inadequate ventilation, unreliable end-tidal carbon dioxide monitoring, and hemodynamic instability.3 Two articles in this issue of the journal address the challenges of selecting ETT size in children with CHD and propose a pragmatic approach tailored to pediatric cardiac practice. Maddali et al.4 report that Cole’s formula for sizing ETTs in children with Down syndrome is not valid, whereas Jayashankar et al.5 recommend using ultrasound-based subglottic diameter measurements to size ETTs. Jayashankar et al. also suggest using the ETT’s outer diameter rather than the internal diameter to determine size. A case report in this issue highlights airway obstruction after multiple intubations, despite a microcuff ETT. The issue was resolved by upsizing the ETT.6 The pediatric airway differs anatomically from the adult airway, with smaller dimensions, greater compliance, and dynamic changes during anesthesia. In children with CHD, these differences are further accentuated by disease-related and genetic factors. Many children with CHD demonstrate failure to thrive due to increased metabolic demand, feeding difficulties, and recurrent infections, resulting in airways that are smaller than predicted by chronological age.7 Several genetic and syndromic conditions commonly associated with CHD, such as trisomy 21 and 22q11 deletion, are associated with craniofacial abnormalities, macroglossia, and subglottic narrowing.8 Extrinsic airway compression may also occur due to cardiomegaly, dilated pulmonary arteries, or vascular rings, further complicating airway management and ETT size selection.9 An oversized ETT may elevate intrathoracic pressure and impair venous return, thereby reducing cardiac output—particularly in patients with single-ventricle physiology or pulmonary hypertension. An undersized ETT may cause excessive air leak, inadequate ventilation, and unreliable capnography. Repeated tube exchanges further increase the risk of airway injury and postoperative morbidity. Age-based formulas are typically used to predict ETT size in children. Studies evaluating their accuracy in children with CHD have shown frequent overestimation of appropriate tube size, particularly in cyanotic and undernourished patients.10 This overestimation increases the risk of airway mucosal injury and post-extubation stridor. Weight- and height-based methods may provide better estimates in healthy children but are unreliable in children with CHD because of disproportionate growth patterns, fluid overload, and altered body composition. The use of cuffed ETTs in pediatric anesthesia has increased substantially with the availability of high-volume, low-pressure cuffs. In children with CHD, cuffed ETTs offer several advantages, including improved ventilation control, reduced air leaks, and accurate end-tidal carbon dioxide measurement.11 Concerns about cuff-related mucosal injury are largely mitigated by appropriate tube sizing and cuff pressure monitoring to maintain cuff pressure below 20–25 cm H2O. Smaller tube sizes can be used, preventing airway injury and the need for up- and downsizing ETTs, which are associated with adverse effects. Current evidence supports the routine use of cuffed ETTs in pediatric cardiac anesthesia when these precautions are followed.12 Point-of-care ultrasound assessment of the subglottic airway diameter has emerged as a valuable adjunct for selecting ETT size in children. Multiple studies show that ultrasound-based measurements correlate more closely with clinically appropriate tube size than age-based formulas.13 In children with CHD, ultrasound is especially useful in neonates and infants with low body weight, patients with syndromic features, and those with a history of prolonged or repeated intubation. USG appears to be a reliable predictor of subglottic airway diameter in children, helping estimate the appropriate ETT size for intubation. Although ultrasound requires specific training and equipment, its use may reduce the need for tube exchange and airway-related complications in high-risk pediatric cardiac patients.14 A proposed practical, CHD-specific approach to optimize airway safety in pediatric cardiac anesthesia is shown in Table 1.Table 1: ETT sizing in CHDFuture studies should focus on developing CHD-specific predictive models for ETT size selection that incorporate anthropometric data, disease severity, and ultrasound-based airway measurements. Prospective multicenter studies in neonates and infants with complex CHD are particularly needed to strengthen the evidence base. ETT size selection in children with CHD requires an individualized approach that extends beyond conventional age-based formulas. Anticipating smaller airways, routinely stocking multiple tube sizes, judicious use of cuffed ETTs with pressure monitoring, and incorporating ultrasound guidance when available are key strategies to improve airway safety and outcomes in pediatric cardiac anesthesia.
MukulChandra Kapoor (Wed,) studied this question.